Formerly Future Meat Technologies. First foreign company to receive US regulatory approval. Built one of the world's largest cultivated meat facilities before shuttering in December 2025 after failing to reach cost targets.
San Diego-based cultivated seafood company developing cell-based fish products including yellowtail and mahi-mahi. Actively fundraising to scale production.
Dutch cultivated meat company that used opti-ox technology for rapid cell differentiation. Acquired Uncommon Bio's platform in 2025 but ceased all operations and entered liquidation in December 2025 after failing to secure continued funding.
UK-based cultivated fat company using computational biology and machine learning to grow real animal fat for use in hybrid products. Filed regulatory submissions in Singapore and UK sandbox.
US cultivated meat company that used CRISPR gene-editing to create cost-efficient bovine cell lines. Ceased operations mid-2025 amid funding challenges.
Infrastructure company developing purpose-built, industrial-scale bioreactors designed specifically for cultivated meat production at food-grade costs.